1. D-Friend INHALABLE INSULIN

2. What is diabetes??
Diabetes is a metabolic diseases in which
the person has high blood glucose (blood
sugar), either because insulin production
is inadequate, or because the body's cells
do not respond properly to insulin, or
both.

3. Type 1 Type 2
 In type 1 diabetes, the
body does not produce
insulin.
 In type 2 diabetes, the
body produces inadequate
amount of insulin.
There are two types of diabetes

5.  382 Million people have diabetes in the world
 More than 34.6 million people in the MENA
Region
 By 2035 this will rise to 67.9 million.
REFERENCE: International Diabetes Federation 2013

6. 9 Bn
1 Bn
6.7M
3.4 M
Deaths 88 K
20-79 years Population
Diabetic Population
Un diagnosed diabetic
REFERENCE: International Diabetes Federation 2013
S
E
G
M
E
N
T
T
A
R
G
E
T

7. REFERENCE: IMS PLUS Q 3 2014

9. •Afrezza is a painless Drug Therapy
•Afrezza is an ultra rapid-acting insulin in powder form that’s designed as a
pre-meal insulin for adults
•The powdered insulin is administered via a whistle-sized inhaler called the
Dreamboat
•The powder dissolves immediately when inhaled into the lungs, and the
insulin’s then quickly dumped into the bloodstream to start working
•Afrezza peaks within 12 to 15 minutes and is out of the system within an
hour, compared to current short-term insulin that usually take at least 20
minutes to kick in, peak at 2-3 hours, and can stay in the system for as long
as five hours.

11.  Brand philosophy:
 Afrezza is the name given because
Tecnosphere technology includes dry
freezing procedure .
 Brand persona:
Brand given Blue color because diabetes
is denoted by blue color world wide and
a brand mascot D-Friend is developed
for brand Recognition and Brand loyalty.
D-Friend

12. Dosage Pack size Retail Price Per unit
4 Unit Cartridge 30’s 2500 83
8 Unit Cartridge 30’s 3000 100
Re-Usable Inhaler (5 Years
Warranty)=Rs.2500

13.  Afrezza will be available at every Hospital
Pharmacy Pan Pakistan.
 Street Pharmacies and Medical stores nearby
Diabetes consultants clinics.
 Sanofi Channel Partner M&P will be the
distributor and 15% discount will be offered
to them on Retail price.

14. PUSH STRATEGY
SANOFI
PRESCRIBERS
PATIENTS
Personal Selling(50 SPO)
Promotional
Support
Free Samples(30
Cartridges/Month/SPO)
Stand Banners (500) in
large hospitals and clinics
Product
Literature(50/SPO/Month)

15. CALL CENTRE
• Call centre for
Home delivery
& Queries
DIABETIC
EDUCATOR
• 25 Trained
educators
• Diet Plan &
Life style
Guidance
SYMPOSIUM
• Seminars and
symposiums for
Doctors to
understand new
technology

16. •Sanofi is a multinational company
•Our Sales Team penetration In
diabetes.
•Diabetic educators team
•Our Training & Development
•Our injectible insulin and other oral
anti diabetic drugs.
•Treatment options are pain full
•Rapid onset of action
•First mover advantage
•Patent rights of next 5 years.
•Regulatory issues
•Acceptance of the new technology.
Strength Weakness
ThreatsOpportunity

17. VISION:
“To be a diversified healthcare leader , focused
on patients need”
MISSION
“To enhance the quality of life of the greatest
number through providing a continuum of
care by answering unmet medical needs of
the community and promoting access to
healthcare”

19. PROFIT & LOSS

21. Direct Expense % sales Direct Expense % sales Direct Expense % sales
2,500,000 1.16%
150,000 0.07% 150,000 0.07% 150,000 0.07%
3,500,000 1.63% 1,500,000 0.70% 1,000,000 0.47%
2,000,000 0.93% 500,000 0.23% 500,000 0.23%
4,500,000 2.10% 900,000 0.42% 900,000 0.42%
1,200,000 0.56% 600,000 0.28% 600,000 0.28%
1,000,000 0.47% 500,000 0.23% 200,000 0.09%
1,000,000 0.47% - 0.00% - 0.00%
2,000,000 0.93% 1,000,000 0.47% 500,000 0.23%
17,850,000 8.32% 5,150,000 2.40% 3,850,000 1.79%
214,625,000 16.63% 266,135,000 4.80% 330,007,400 3.59%
PROMO EXPENSE
20172015 2016
Launch / Training
Printed / Promotional material
Give aways / Display material
Advertisement/ Medical Conferences
Sample Cost
Incentive
Product Presentation/RTM
Launching Cost
Dr Obligation/ Sponsorships
Total Rs (Promotional)
Total Rs.(Product)
Budget Head